Successful treatment of extremely large Bowen's disease lesion by topical photodynamic therapy and imiquimod: Using optical coherence tomography to detect early recurrence loci and validate the cure

Photodiagnosis Photodyn Ther. 2023 Mar:41:103201. doi: 10.1016/j.pdpdt.2022.103201. Epub 2022 Nov 12.

Abstract

Bowen's disease, a form of skin cancer, is an intraepithelial carcinoma involving keratinocytes. It is associated with a risk of developing invasive squamous cell carcinoma in 3-5% of cases. Ultraviolet exposure, arsenic, human papillomavirus infection, immunosuppression, and genetic factors have been reported to be the causes. Clinically, it presents as symptomless and slowly growing, well-demarcated, irregular erythematous patches or plaques with scaly or crusted surfaces. Surgical excision remains common; however, for large (>20 mm) or multiple Bowen's disease lesions, alternative therapies need to be considered. Here, we present a case of extremely large Bowen's disease lesions in the lower extremities successfully treated with combination therapy using topical aminolevulinic acid-based photodynamic therapy followed by topical 5% imiquimod cream. Optical coherence tomography revealed disorganized and uneven nuclei of keratinocytes in the recurrent lesions, which became relatively small and uniform upon resolution. We demonstrated that photodynamic therapy provides a generally safe and effective strategy for treating large Bowen's disease lesions and optical coherence tomography provides a useful and noninvasive diagnosis of early Bowen's disease recurrence.

Keywords: Bowen's disease; Imiquimod; Optical coherence tomography; Photodynamic therapy.

Publication types

  • Case Reports

MeSH terms

  • Aminoquinolines / therapeutic use
  • Bowen's Disease* / drug therapy
  • Bowen's Disease* / pathology
  • Humans
  • Imiquimod / therapeutic use
  • Photochemotherapy* / methods
  • Photosensitizing Agents / therapeutic use
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / pathology
  • Tomography, Optical Coherence

Substances

  • Imiquimod
  • Aminoquinolines
  • Photosensitizing Agents